Home » Vaccines: Aifa approves Moderna for the 12-17 age group – Healthcare

Vaccines: Aifa approves Moderna for the 12-17 age group – Healthcare

by admin

The Technical Scientific Commission (CTS) of AIFA has approved the extension of indication of use of the Spikevax (Moderna) vaccine for the age group between 12 and 17 years, fully accepting the opinion expressed by the European Medicines Agency (EMA ). According to the CTS, in fact, the available data demonstrate the efficacy and safety of the vaccine even for subjects included in this age group.

breaking latest news © Copyright ANSA


This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy